Home/Filings/4/0001562180-24-007353
4//SEC Filing

Carruthers R Michael 4

Accession 0001562180-24-007353

CIK 0001710072other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:23 PM ET

Size

6.8 KB

Accession

0001562180-24-007353

Insider Transaction Report

Form 4
Period: 2024-10-11
Carruthers R Michael
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-1170,000127,122 total
    Exercise: $0.71From: 2024-09-01Exp: 2030-09-01Common Stock (70,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-10-11$0.71/sh+70,000$49,70076,904 total

Issuer

Edgewise Therapeutics, Inc.

CIK 0001710072

Entity typeother

Related Parties

1
  • filerCIK 0001644467

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:23 PM ET
Size
6.8 KB